| 发明名称 |
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB |
| 摘要 |
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders. |
| 申请公布号 |
HK1213796(A1) |
申请公布日期 |
2016.07.15 |
| 申请号 |
HK20160101836 |
申请日期 |
2016.02.18 |
| 申请人 |
Incyte Holdings Corporation |
发明人 |
Yong NI;Bhavnish PARIKH;Krishnaswamy YELESWARAM;Susan ERICKSON-VIITANEN;William V. WILLIAMS |
| 分类号 |
A61K |
主分类号 |
A61K |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
